论文部分内容阅读
Aim: Rheumatoid arthritis (RA) is a chronic inflammatory disease, In order to evaluate the efficacy and safety of iguratimod in treatment for RA patients in China, an initial clinical trial was conducted.Methods: 1) Clinical pharmacokinetics of iguratimod was studied on healthy Chinese humans: 32 healthy volunteers were divided into four groups.